Enzyme inhibition in drug discovery and development : the good and the bad /
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Hoboken, N.J. :
Wiley,
[2010]
|
| Subjects: |
Table of Contents:
- The drug discovery process
- Medicinal chemistry of the optimization of enzyme inhibitors
- Bioanalytical technologies in drug discovery
- Safety biomarkers in drug development : emerging trends and implications
- The role of drug metabolism in drug discovery
- Applied pharmacokinetics in drug discovery and development
- Enzyme inhibition and inactivation : cytochrome P450 enzymes
- Cytochrome P450 induction
- Inhibition of drug-metabolizing enzymes in gastrointestinal tract and its influence on the drug-drug interaction prediction
- Enzyme inhibition in various in vitro systems
- Cytochrome P450 degradation and its clinical relevance
- Complexities of working with UDP-glucuronosyltransferases (UGTs) : focus on enzyme inhibition
- Evaluation of inhibitors of drug metabolism in human hepatocytes
- Grapefruit juice and its constituents as new esterase inhibitors
- Transporter-xenobiotic interactions : an important aspect of drug development studies
- Polymorphisms of drug transporters and their clinical implications
- Clinical drug interactions due to metabolic inhibition : prediction, assessment, and interpretation
- Predicting interindividual variability of metabolic drug-drug interactions : identifying the causes and accounting for them using a systems approach
- NF-kB : mechanism, tumor biology, and inhibitors
- G-protein-coupled receptors as drug targets
- Pharmacological modulation of ion channels for the treatment of chronic pain
- Targeting the mTOR pathway for tumor therapeutics
- HIV-1 protease inhibitors as antiretroviral agents